Àü³²´ëÇб³º´¿ø È£Èí±â³»°ú ±è¿µÃ¶ ±³¼ö°¡ Áö³ 28ÀÏ ¹Ð·¹´Ï¾ö ÈúÆ°È£ÅÚ¿¡¼ °³ÃÖµÈ ´ëÇÑÆó¾ÏÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ‘3B ¶Ç´Â 4º´±â ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼ÀÇ docetaxel, cisplatin ¿ë·® ºñ±³ ¿¬±¸’(A Randomized trial of 1st line Docetaxel and Cisplatin in 75/60 vs 60/60 mg/m2 for patients with stage ¥² B or ¥³ Non-Small Cell Lung Cancer - an Interim Analysis)¶ó´Â ÁÖÁ¦ ³í¹®À¸·Î ¿ì¼ö ¿¬Á¦»óÀ» ¼ö»óÇß´Ù.
±è¿µÃ¶ ±³¼ö´Â ´ëÇѳ»°úÇÐȸ, ´ëÇÑ °áÇÙ ¹× È£Èí±â ÇÐȸ, ¹Ì±¹ È£Èí±âÇÐȸ µî È°¹ßÇÑ ÇÐȸȰµ¿À» ÇÏ°í ÀÖÀ¸¸ç, Àü³²´ëº´¿ø¿¡¼ Æó¾Ï, È£Èí±â Áúȯ µîÀ» Àü¹®ÀûÀ¸·Î Ä¡·áÇÏ°í ÀÖ´Ù.
ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.